Science, medicine, and the future: Allergic disorders
- 22 January 2000
- Vol. 320 (7229) , 231-234
- https://doi.org/10.1136/bmj.320.7229.231
Abstract
Methods I identified those aspects of allergy research with the greatest potential for novel therapeutic approaches from my personal knowledge of the subject. The information sources for the article are peer reviewed reports of original observations and, where appropriate, reviews of the recent literature by established investigators.Keywords
This publication has 23 references indexed in Scilit:
- Role of microbial burden in aetiology of allergy and asthmaThe Lancet, 1999
- Tick Histamine-Binding ProteinsMolecular Cell, 1999
- Injection of anti-IgE antibodies will suppress IgE and allergic symptoms.1999
- Bacterial CpG DNA Activates Immune Cells to Signal Infectious DangerPublished by Elsevier ,1999
- Inhibition of an established allergic response to ovalbumin in BALB/c mice by killed Mycobacterium vaccaeImmunology, 1998
- Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis☆☆☆★★★Journal of Allergy and Clinical Immunology, 1997
- Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.Journal of Clinical Investigation, 1997
- The Inverse Association Between Tuberculin Responses and Atopic DisorderScience, 1997
- Design of human interleukin‐4 antagonists inhibiting interleukin‐4‐dependent and interleukin‐13‐dependent responses in T‐cells and B‐cells with high efficiencyEuropean Journal of Biochemistry, 1994
- Allergy treatment with a peptide vaccineThe Lancet, 1990